Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001372514-24-000107)

Filing Details

Accession Number:: 0001372514-24-000107
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-15 16:17:41
Reporting Period:: 2024-08-14

Accepted Time:: 2024-08-15 16:17:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1372514	Kiora Pharmaceuticals Inc	KPRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1947184	Melissa Tosca	C/O Kiora Pharmaceuticals, Inc. 332 Encinitas Blvd., Suite 102 Encinitas CA 92024	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-08-14	2,000	$3.21	13,599	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares were purchased in multiple transactions at prices ranging from $3.16 to $3.26. The reported price of $3.21 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.